A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
Condition(s):Depressive Disorder, MajorLast Updated:October 29, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Depressive Disorder, MajorLast Updated:October 29, 2018Completed
Condition(s):Major Depressive DisorderLast Updated:August 14, 2019Completed
Condition(s):Major Depressive DisorderLast Updated:August 14, 2019Completed
Condition(s):None (i.e. Healthy Volunteers)Last Updated:October 6, 2021Active, not recruiting
Condition(s):Arthritis, RheumatoidLast Updated:November 17, 2014Completed
Condition(s):Systemic Lupus Erythematosus; Widespread Pain; FibromyalgiaLast Updated:September 18, 2015Withdrawn
Condition(s):Rheumatoid ArthritisLast Updated:March 29, 2018Completed
Condition(s):Vestibulodynia; VulvodyniaLast Updated:June 11, 2018Completed
Condition(s):FibromyalgiaLast Updated:January 26, 2012Completed
Condition(s):Knee Pain After Total Knee Arthroplasty; Osteoarthritis PainLast Updated:February 6, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.